Halozyme Therapeutics in (halo 1 08/15/28)
13F holders, Q1 2024 (March 31)9holders
$1.15avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Halozyme Therapeutics in (halo 1 08/15/28) in their 13F filings. The largest holders were Absolute Investment Advisers, LLC ($10.8M), Ofi Invest Asset Management ($9.2M) and New York State Common Retirement Fund ($4.9M).
- Company
- Halozyme Therapeutics in (halo 1 08/15/28)
- CUSIP
- 40637HAF6
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2.3M |
| Exits | 2 | $416K |
Ownership 9 holders
| Absolute Investment Advisers, LLC | 1.47% | No change | 11,000,000 | $10.8M |
| Ofi Invest Asset Management | 0.25% | Add +111375.0% | 4,904,900 | $9.2M |
| New York State Common Retirement Fund | 0.01% | Add +4.7% | 4,993,000 | $4.9M |
| Sonora Investment Management Group, LLC | 0.18% | New | 2,335,000 | $2.3M |
| Jane Street Group, LLC | 0.00% | Reduce -64.2% | 1,360,000 | $1.3M |
| Bank of New York Mellon Corp | 0.00% | No change | 600,000 | $585K |
| Sei Investments Co. | 0.00% | No change | 322,000 | $313K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -45.2% | 108,000 | $105K |
| Stephens Inc. | 0.00% | Add +48.6% | 104,000 | $101K |
"% of holder's portfolio" is HALOZYME THERAPEUTICS IN (HALO 1 08/15/28)'s weight in each manager's 13F, not the share of Halozyme Therapeutics in (halo 1 08/15/28) the manager owns.